SHENZHEN, ChinaPRNewswire via COMTEX/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, has announced updates on new product launches for 2009 and its product pipeline for domestic and international markets in 2010.

In 2009 the Company released a total of ten products, exceeding new product development goals outlined at the beginning of the year and increasing its total number of products on the market to over 70. Seven of the new products came from its patient monitoring and life support product line, including: two patient monitors, the Accutorr V and Passport V; the NetGuard clinical alert system; the WATO EX20/30 anesthesia machines; the Company's first surgical lights HyLite 6700/6500; its first surgical bed HyBase 6100; and its first ceiling pendent systems HyPort 3000/6000/8000. Mindray also released two new products in the medical imaging product line, including the DC-7 color ultrasound system, the DP 6900 portable black and white ultrasound system and one new product, the BC 5800 hematology analyzer, in the in-vitro diagnostic product line.

2010 New Product Pipeline

To further expand the addressable markets, the Company expects to launch between seven and ten new products in 2010 with an emphasis on higher end market opportunities. In 2010, the patient monitoring and life support product lines will yield additional products and enhancements. Areas for planned product expansion include patient monitoring, anesthesia delivery, surgical lights, surgical beds and ceiling pendent systems. For the in-vitro diagnostic product line, we plan to develop a more advanced biochemistry analyzer and several reagents. Additionally, the medical imaging product line plans to unveil a feature enhanced portable color ultrasound unit and a more advanced digital radiography system.

"In 2009 we continued our aggressive pace of product development," commented Mr. Xu Hang, Mindray's chairman and co-chief executive officer. "In this uncertain and increasingly price-competitive healthcare market, Mindray remains committed to innovating to meet the specific needs of our customers in various geographies. In 2010, Mindray plans to launch another seven to ten new products to support our continued growth. Strategically, we plan to launch more high-end products to help us penetrate into the higher-end market segments. Additionally, we will continue to realize synergies with Mahwah operations with expansion plans for both the patient monitoring and anesthesia delivery product lines. New products will fuel additional cross-selling and market share gain opportunities. There is no doubt that 2010 brings a number of uncertainties for medical device companies, but Mindray is well positioned and prepared to continue to meet the market's ever-changing needs."

About Mindray

We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://ir.mindray.com .

More HCB News